Alliance for Representative
Clinical Trials

Ethnically and racially diverse audiences are underrepresented in clinical trials.

National Minority Quality Forum (NMQF) has launched the Alliance for Representative Clinical Trials (ARC). ARC is a multi-sponsor public/private program organized to diversify and bring clinical trials to communities of color and other communities that have been underrepresented in clinical trials.

ARC has two distinct but related programs:

1) The PI Institute that trains community clinicians to be clinical trial principal investigators (PIs)

2) Clinical Investigative Site Network (CISN), which conducts sponsored clinical trials through a network of PI Institute graduates

In this site, ARC explores:


A Look Into Disparities

Caucasians make up 68% of the U.S. population but are 93.4% of research participants. 
Black/African Americans make up 13.6% of the U.S. population, but only 5.6% of trial participants. 
Hispanic/Latinos represent 18.4% of the U.S. population, but are 1% of the trial.

A Need For Change


ARC was launched to create a network of community clinicians that is organized to diversify and bring clinical trials to communities of color and other communities that have been underrepresented in clinical trials.

 

This collaborative effort allows for a significant sample size of the minority population to be included in clinical trials by including community clinic participation, thus providing sufficient power for drawing meaningful conclusions that would otherwise exclude minorities and not account for their health outcomes.

LEARN MORE

 

Learn More